In the news - Novasecta: Pharma focused, bespoke solutions

Media

Explore our comment, insight and articles by media organisations and specialist pharmaceutical journals.

For our white papers and perspectives on topics that our clients care about see here

How European MidPharmas have Grown Profits (MedNous)

How R&D Teams Create Value from On-Market Products (MedNous)

How Pharma Manages Organisational Complexity (MedNous)

AstraZeneca sacrifices revenue with a no-profit Covid-19 vaccine (Daily Mail)

Oxford vaccine news is very encouraging (CNBC)

Novo Nordisk showed ‘extraordinary growth’ but faces competitive weight loss market (CNBC)

Vaccine nationalism could be devastating (CNBC)

Bayer settles but is its future path clear? (Deutsche Welle)

Is a mega merger the best option? (CNBC)

AstraZeneca eyes up Gilead (Bloomberg)

Continued innovation pays for Big Pharma (CNBC)

Strategic focus allows Novartis to raise sales targets (CNBC)

Resources

Insights

Discover new perspectives and approaches to address industry challenges

Client Stories

Find out what our clients have achieved with us, and how

Media

Stay up to date with our press comment and specialist journal articles

WHAT OUR CLIENTS
SAY ABOUT US

I value how Novasecta really understands and cares about our business, and how they manage to apply their deep industry insights to our context.

CEO – Biotech